However, while these treatments can be life-changing, patients can’t always access them.The most common avenue of treatment ...

Capricor's biologics license application for deramiocel (CAP-1002) is draws largely on the Phase 2 HOPE-2 trial and its ...

"I think more people react positively with a diagnosis of something. I have several patients this week that was recently diagnosed with borderline diabetes, and they immediately started losing weight, ...

In 2024, the company forged new partnerships with three of the largest, global pharmaceutical companies in the world, realizing a total of 10 partnerships with leading life science companies. Viz.ai ...

Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...

More than one million people in the UK have heart failure, with 200,000 new diagnoses every year. It can be easy to miss in ...

If you always feel sleepy and sluggish, you might want to take it as a warning sign as a doctor has cautioned it could a heart problem ...

Alnylam's TTR franchise, powered by Amvuttra, poised for $7.5B peak revenue with undervalued shares and long-term growth ...